# FDA Inspection 1091704 - Department of the Air Force - 31st Medical Group/SGSAL - April 30, 2019

Source: https://www.keypedia.com/records/fda_inspections/department-of-the-air-force-31st-medical-groupsgsal/d8c0d67d-cf4b-4e0f-8bbd-8664f206c8f5
Source feed: FDA_Inspections

> FDA Inspection 1091704 for Department of the Air Force - 31st Medical Group/SGSAL on April 30, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1091704
- Company Name: Department of the Air Force - 31st Medical Group/SGSAL
- Inspection Date: 2019-04-30
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1014505 - 2017-05-05](https://www.keypedia.com/records/fda_inspections/department-of-the-air-force-31st-medical-groupsgsal/9562198d-f40f-4b36-addb-d8423217d960)
- [FDA Inspection 931079 - 2015-06-04](https://www.keypedia.com/records/fda_inspections/department-of-the-air-force-31st-medical-groupsgsal/c8af9705-a944-4fae-ab32-71ccfe98f226)
- [FDA Inspection 836850 - 2013-06-11](https://www.keypedia.com/records/fda_inspections/department-of-the-air-force-31st-medical-groupsgsal/48636f50-f6f3-4542-b178-bdf8e343c09b)
- [FDA Inspection 738109 - 2011-06-14](https://www.keypedia.com/records/fda_inspections/department-of-the-air-force-31st-medical-groupsgsal/cca101ca-ee11-46da-b898-d5cf1ce91c02)
- [FDA Inspection 593161 - 2009-05-28](https://www.keypedia.com/records/fda_inspections/department-of-the-air-force-31st-medical-groupsgsal/e0ee0f50-c979-4ff8-aa01-42c6bc8d08d2)

Company: https://www.keypedia.com/companies/department-of-the-air-force-31st-medical-groupsgsal/6caa39ba-f17f-4286-8f38-96fe60f18f62

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d